跳至主要内容
临床试验/NCT03278249
NCT03278249Unknown不适用

Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma

University of Cincinnati2 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2017年10月12日最近更新:
适应症

试验速览

阶段
不适用
入组人数
11
试验地点
2
主要终点
Number of Participants With Ketosis

研究概览

简要总结

The purpose of this research study is to see if people can produce ketones in their blood with the modified Atkins diet. Modified Atkins diet is a diet that produces ketones in your blood by restricting carbohydrates to <20 grams per day. Ketones are substances that are produced in the blood when fat is being broken down. Ketones may help radiation work better and may starve your tumor because it is thought that some brain tumors can not use ketones to grow and can only use sugar or glucose to grow.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically confirmed primary malignant glioma, Grade III or IV
  • No uncontrolled infection or other active malignancy or chronic systemic immune therapy.
  • ECOG performance status <
  • Life expectancy > three months.
  • Adequate labs

排除标准

  • Diagnosis of genetic disorder of fat metabolism.
  • Type 2 diabetes diagnosed with a hemoglobin A1C > 6.4
  • Allergic to dairy or lactose intolerance

结局指标

主要结局

Number of Participants With Ketosis

时间窗: 6 weeks

Ketosis measured by serum beta-hydroxybuterate. Ketosis is defined as having serum beta-hydroxybuterate (BHB) at \> 0.05 mM. Participants' BHB levels were assessed at 6 weeks after starting the study. The number of participants who had BHB at \> 0.05 mM were considered to have entered into ketosis. 9 of 9 participants met this criteria.

次要结局

  • Number of Participants With Progression Free Survival(6 months)
  • Assessment of Survival(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rekha Chaudhary

Associate Professor of Medicine

University of Cincinnati

研究点 (2)

Loading locations...

相似试验